Rosie Collington is a Junior Researcher with the Academic-Industry Research Network and MSc student at the University of Copenhagen. She has previously worked in health policy and advocacy at medical research and patient organizations in the UK.
Rosie Collington
By this expert
Beyond Price Caps: A Regulatory Framework for Pricing of Medicine Innovation
US regulators can step in to ensure drug pricing both supports patient access and drug development
Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access
US regulators can step in to ensure drug pricing both supports patient access and drug development
Who Benefits When the Price of Insulin Soars?
Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D
Profits, Innovation and Financialization in the Insulin Industry
This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.
Featuring this expert
Think Big Pharma Won’t Profiteer in the Race to Treat Coronavirus? Think Again.
Evidence shows pharmaceutical companies won’t stop price-gouging and risking American lives for financial gain in this time of crises – unless we force them.